 BOULDER, Colo., Nov. 10, 2020 GLOBE NEWSWIRE -- miRagen Therapeutics, Inc. NASDAQ: MGEN, a biotechnology company advancing new treatments for patients with diseases that are underserved by current therapies, today announced financial results for the third quarter ended September 30, 2020 and provided corporate updates. 